cardiovascular disease

Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production
Gut Dec 2024, 73 (12) 1934-1943; DOI: 10.1136/gutjnl-2024-331880
Familial coaggregation of inflammatory bowel disease with cardiovascular disease: a nationwide multigenerational cohort study
Jiangwei Sun, Jialu Yao, Ola Olén, Jonas Halfvarson, David Bergman, Fahim Ebrahimi, Johan Sundström, Jonas F Ludvigsson

Gut Nov 2024, 73 (11) e23; DOI: 10.1136/gutjnl-2023-331632
Dietary fibre (and animal products) modulate the association between tryptophan intake, gut microbiota and type 2 diabetes: but how?
Lin Shi, Rikard Landberg

Gut Jun 2024, 73 (6) 884-886; DOI: 10.1136/gutjnl-2023-330972
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
Hyeok-Hee Lee, Han Ah Lee, Eun-Jin Kim, Hwi Young Kim, Hyeon Chang Kim, Sang Hoon Ahn, Hokyou Lee, Seung Up Kim

Gut Mar 2024, 73 (3) 533-540; DOI: 10.1136/gutjnl-2023-331003
Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals
Alessandro Mantovani, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher

Gut Jul 2023, 72 (7) 1433-1436; DOI: 10.1136/gutjnl-2022-328224
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort
Tracey G Simon, Bjorn Roelstraete, Hannes Hagström, Johan Sundström, Jonas F Ludvigsson

Gut Sep 2022, 71 (9) 1867-1875; DOI: 10.1136/gutjnl-2021-325724
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals
Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, Giorgia Beatrice, Stefano Bonapace, Andrea Rossi, Herbert Tilg, Christopher D Byrne, Giovanni Targher

Gut Feb 2023, 72 (2) 372-380; DOI: 10.1136/gutjnl-2022-327672
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease
Tracey G Simon, Bjorn Roelstraete, Naim Alkhouri, Hannes Hagström, Johan Sundström, Jonas F Ludvigsson

Gut Mar 2023, 72 (3) 573-580; DOI: 10.1136/gutjnl-2022-328105
Optimising the management of cardiovascular comorbidities in NAFLD patients: it’s time to (re-) act!
Philipp Kasper, Sonja Lang, Muenevver Demir, Hans-Michael Steffen

Gut Nov 2022, 71 (11) 2365-2366; DOI: 10.1136/gutjnl-2021-326662
Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed
Christopher D Byrne, Giovanni Targher

Gut Sep 2022, 71 (9) 1695-1696; DOI: 10.1136/gutjnl-2021-325965

Main menu

cardiovascular disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

cardiovascular disease

Pages